The role of miR-378a in metabolism, angiogenesis, and muscle biology

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Krist, Bart ^a   Florczyk, Urszula ^a   Pietraszek Gremplewicz, Katarzyna ^a   Józkowicz, Alicja ^a   Dulak, Jozef ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 378A; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANGIOGENESIS; BIOGENESIS; ENERGY METABOLISM; GENE SILENCING; GLYCOLYSIS; HUMAN; INFLAMMATION; LIPID METABOLISM; METABOLISM; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA SEQUENCE; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 84957095420     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/281756     Document Type: Review

References (132)

1. Z. Wang, Z. Ying, A. Bosy-Westphal, et al., "Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure, " The American Journal of Clinical Nutrition, vol. 92, no. 6, pp. 1369-1377, 2010.
2. K. L. Blaxter, Energy Metabolism in Animals and Man, Cambridge University Press, Cambridge, UK, 1989.
3. D. Gallagher, D. Belmonte, P. Deurenberg, et al., "Organ-tissue mass measurement allows modeling of REE and metabolically active tissuemass, " American Journal of Physiology, vol. 275, no. 2, part 1, pp. E249-E258, 1998.
4. M. N. Poy, M. Spranger, and M. Stoffel, "microRNAs and the regulation of glucose and lipid metabolism, " Diabetes, Obesity and Metabolism, vol. 9, supplement 2, pp. 67-73, 2007.
5. L. J. Eichner, M. C. Perry, C. R. Dufour, et al., "miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1/ERR transcriptional pathway, " Cell Metabolism, vol. 12, no. 4, pp. 352-361, 2010.
6. M. Carrer, N. Liu, C. E. Grueter, et al., "Control ofmitochondrial metabolism and systemic energy homeostasis by microRNAs and 378∗, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 38, pp. 15330-15335, 2012.
7. J. Gagan, B. K. Dey, R. Layer, Z. Yan, and A. Dutta, "MicroRNA-targets the myogenic repressor MyoR during myoblast differentiation, "The Journal of Biological Chemistry, vol. 286, no. 22, pp. 19431-19438, 2011.
8. D. Y. Lee, Z. Deng, C.-H. Wang, and B. B. Yang, "MicroRNA-promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 51, pp. 20350-20355, 2007.
9. L.-T. Chen, S.-D. Xu, H. Xu, J.-F. Zhang, J.-F. Ning, and S.-F. Wang, "MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis, " Medical Oncology, vol. 29, no. 3, pp. 1673-1680, 2012.
10. I. Lee, S. S. Ajay, I. Y. Jong, et al., "New class of microRNA targets containing simultaneous 5-UTR and 3-UTR interaction sites, " Genome Research, vol. 19, no. 7, pp. 1175-1183, 2009.
11. R. C. Lee, R. L. Feinbaum, and V. Ambros, "The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, " Cell, vol. 75, no. 5, pp. 843-854, 1993.
12. B. P. Lewis, C. B. Burge, and D. P. Bartel, "Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, " Cell, vol. 120, no. 1, pp. 15-20, 2005.
13. I. Bentwich, "Prediction and validation of microRNAs and their targets, " FEBS Letters, vol. 579, no. 26, pp. 5904-5910, 2005.
14. R. C. Friedman, K. K.-H. Farh, C. B. Burge, and D. P. Bartel, "Most mammalian mRNAs are conserved targets of microRNAs, " Genome Research, vol. 19, no. 1, pp. 92-105, 2009.
15. S.-Y. Ying and S.-L. Lin, "Intronic microRNAs, " Biochemical and Biophysical Research Communications, vol. 326, no. 3, pp. 515-520, 2005.
16. S. Baskerville and D. P. Bartel, "Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes, " RNA, vol. 11, no. 3, pp. 241-247, 2005.
17. Y. Lee, M. Kim, J. Han, et al., "MicroRNA genes are transcribed by RNA polymerase II, " The EMBO Journal, vol. 23, no. 20, pp. 4051-4060, 2004.
18. Y. Altuvia, P. Landgraf, G. Lithwick, et al., "Clustering and conservation patterns of human microRNAs, " Nucleic Acids Research, vol. 33, no. 8, pp. 2697-2706, 2005.
19. E. P. Murchison and G. J. Hannon, "miRNAs on the move: miRNA biogenesis and the RNAi machinery, " Current Opinion in Cell Biology, vol. 16, no. 3, pp. 223-229, 2004.
20. A. E. Pasquinelli, "MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship, " Nature Reviews Genetics, vol. 13, no. 4, pp. 271-282, 2012.
21. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function, " Cell, vol. 116, no. 2, pp. 281-297, 2004.
22. K. Kasashima, Y. Nakamura, and T. Kozu, "Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells, " Biochemical and Biophysical Research Communications, vol. 322, no. 2, pp. 403-410, 2004.
23. M. S. Stark, S. Tyagi, D. J. Nancarrow, et al., "Characterization of the melanoma miRNAome by deep sequencing, " PLoS ONE, vol. 5, no. 3, Article ID e9685, 2010.
24. D. D. Jima, J. Zhang, C. Jacobs, et al., "Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs, " Blood, vol. 116, no. 23, pp. e118-e127, 2010.
25. E. Berezikov, G. Van Tetering, M. Verheul, et al., "Many novelmammalian microRNAcandidates identified by extensive cloning and RAKE analysis, " Genome Research, vol. 16, no. 10, pp. 1289-1298, 2006.
26. L. A. Goff, J. Davila, M. R. Swerdel, et al., "Ago2 immunoprecipitation identifies predictedMicroRNAs in human embryonic stem cells and neural precursors, " PLoS ONE, vol. 4, no. 9, Article ID e7192, 2009.
27. M. Dannemann, K. Prüfer, E. Lizano, B. Nickel, H. A. Burbano, and J. Kelso, "Transcription factors are targeted by differentially expressed miRNAs in primates, " Genome Biology and Evolution, vol. 4, no. 4, pp. 552-564, 2012.
28. A. Kozomara and S. Griffiths-Jones, "MiRBase: integrating microRNA annotation and deep-sequencing data, " Nucleic Acids Research, vol. 39, no. 1, pp. D152-D157, 2011.
29. I. Gerin, G. T. Bommer, C. S. McCoin, K. M. Sousa, V. Krishnan, and O. A. MacDougald, "Roles for miRNA-378/378∗ in adipocyte gene expression and lipogenesis, "American Journal of Physiology-Endocrinology and Metabolism, vol. 299, no. 2, pp. E198-E206, 2010.
30. X. Hou, Z. Tang, H. Liu, N. Wang, H. Ju, and K. Li, "Discovery of MicroRNAs associated with myogenesis by deep sequencing of serial developmental skeletalmuscles in pigs, " PLoSONE, vol. 7, no. 12, Article ID e52123, 2012.
31. J. Lin, P. Puigserver, J. Donovan, P. Tarr, and B. M. Spiegelman, "Peroxisome proliferator-activated receptor coactivator 1 (PGC-1), a novel PGC-1-related transcription coactivator associated with host cell factor, " The Journal of Biological Chemistry, vol. 277, no. 3, pp. 1645-1648, 2002.
32. I. S. Patten and Z. Arany, "PGC-1 coactivators in the cardiovascular system, " Trends in Endocrinology and Metabolism, vol. 23, no. 2, pp. 90-97, 2012.
33. Y. Kamei, H. Ohizumi, Y. Fujitani, et al., "PPAR coactivator 1/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12378-12383, 2003.
34. J. Lin, R. Yang, P. T. Tarr, et al., "Hyperlipidemic effects of dietary saturated fatsmediated through PGC-1 coactivation of SREBP, " Cell, vol. 120, no. 2, pp. 261-273, 2005.
35. J. Lin, P. T. Tarr, R. Yang, et al., "PGC-1 in the regulation of hepatic glucose and energy metabolism, " The Journal of Biological Chemistry, vol. 278, no. 33, pp. 30843-30848, 2003.
36. C. Wolfrumand M. Stoffel, "Coactivation of Foxa2 through Pgc-1 promotes liver fatty acid oxidation and triglyceride/VLDL secretion, " Cell Metabolism, vol. 3, no. 2, pp. 99-110, 2006.
37. J. St-Pierre, J. Lin, S. Krauss, et al., "Bioenergetic analysis of peroxisome proliferator-activated receptor coactivators 1 and 1 (PGC-1 and PGC-1) in muscle cells, " The Journal of Biological Chemistry, vol. 278, no. 29, pp. 26597-26603, 2003.
38. E. M. Small and E. N. Olson, "Pervasive roles of microRNAs in cardiovascular biology, " Nature, vol. 469, no. 7330, pp. 336-342, 2011.
39. E. vanRooij, D. Quiat, B. A. Johnson, et al., "Afamily ofmicroRNAs encoded by myosin genes governs myosin expression and muscle performance, " Developmental Cell, vol. 17, no. 5, pp. 662-673, 2009.
40. S. Wang, A. B. Aurora, B. A. Johnson, et al., "The endothelialspecific microRNA miR-126 governs vascular integrity and angiogenesis, " Developmental Cell, vol. 15, no. 2, pp. 261-271, 2008.
41. T. Mohri, M. Nakajima, T. Fukami, M. Takamiya, Y. Aoki, and T. Yokoi, "Human CYP2E1 is regulated by miR-378, " Biochemical Pharmacology, vol. 79, no. 7, pp. 1045-1052, 2010.
42. T.-I. Jeon, J. W. Park, J. Ahn, C. H. Jung, and T. Y. Ha, "Fisetin protects against hepatosteatosis in mice by inhibiting miR-378, " Molecular Nutrition & Food Research, vol. 57, no. 11, pp. 1931-1937, 2013.
43. Z. Arany, N. Lebrasseur, C. Morris, et al., "The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle, " Cell Metabolism, vol. 5, no. 1, pp. 35-46, 2007.
44. Y. Mallat, E. Tritsch, R. Ladouce, et al., "Proteome modulation in H9c2 cardiac cells by microRNAs miR-378 and miR-378, " Molecular and Cellular Proteomics, vol. 13, no. 1, pp. 18-29, 2014.
45. G. Ailhaud, P. Grimaldi, and R. Négrel, "Hormonal regulation of adipose differentiation, " Trends in Endocrinology and Metabolism, vol. 5, no. 3, pp. 132-136, 1994.
46. C. Villar-Palasi, "The hormonal regulation of glycogen metabolism in muscle, " Vitamins and Hormones, vol. 26, pp. 65-118, 1968.
47. R. P. Brun, J. B. Kim, E. Hu, S. Altiok, and B. M. Spiegelman, "Adipocyte differentiation: a transcriptional regulatory cascade, " Current Opinion in Cell Biology, vol. 8, no. 6, pp. 826-832, 1996.
48. M. I. Lefterova and M. A. Lazar, "New developments in adipogenesis, " Trends in Endocrinology andMetabolism, vol. 20, no. 3, pp. 107-114, 2009.
49. A. T. Ali, W. E. Hochfeld, R. Myburgh, and M. S. Pepper, "Adipocyte and adipogenesis, " European Journal of Cell Biology, vol. 92, no. 6-7, pp. 229-236, 2013.
50. W. Jin, M. V. Dodson, S. S. Moore, J. A. Basarab, and L. L. Guan, "Characterization of microRNA expression in bovine adipose tissues: a potential regulatory mechanism of subcutaneous adipose tissue development, " BMC Molecular Biology, vol. 11, article 29, 2010.
51. D. V. Chartoumpekis, A. Zaravinos, P. G. Ziros, et al., "Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice, " PLoS ONE, vol. 7, no. 4, Article ID e34872, 2012.
52. S. Collins, C. M. Kuhn, A. E. Petro, A. G. Swick, B. A. Chrunyk, and R. S. Surwit, "Role of leptin in fat regulation, " Nature, vol. 380, no. 6576, p. 677, 1996.
53. P. Trayhurn and D. V. Rayner, "Hormones and the ob gene product (leptin) in the control of energy balance, " Biochemical Society Transactions, vol. 24, no. 2, pp. 565-570, 1996.
54. L.-L. Xu, C.-M. Shi, G.-F. Xu, et al., "TNF-, IL-6, and leptin increase the expression of miR-378, an adipogenesis-related microRNA in human adipocytes, " Cell Biochemistry and Biophysics, vol. 70, no. 2, pp. 771-776, 2014.
55. J. M. Stephens, J. Lee, and P. F. Pilch, "Tumor necrosis factor-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction, " The Journal of Biological Chemistry, vol. 272, no. 2, pp. 971-976, 1997.
56. S. Müller, S. Martin, W. Koenig, et al., "Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors, " Diabetologia, vol. 45, no. 6, pp. 805-812, 2002.
57. I. Knezevic, A. Patel, N. R. Sundaresan, et al., "A novel cardiomyocyte-enriched MicroRNA, miR-378, targets insulinlike growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival, "The Journal of Biological Chemistry, vol. 287, no. 16, pp. 12913-12926, 2012.
58. E. D. Rosen and B. M. Spiegelman, "Peroxisome proliferator-activated receptor ligands and atherosclerosis: ending the heartache, " The Journal of Clinical Investigation, vol. 106, no. 5, pp. 629-631, 2000.
59. L. Fajas, D. Auboeuf, E. Raspé, et al., "The organization, promoter analysis, and expression of the human PPAR gene, " The Journal of Biological Chemistry, vol. 272, no. 30, pp. 18779-18789, 1997.
60. J. R. Zierath and H. Wallberg-Henriksson, Muscle Metabolism, Frontiers in Animal Diabetes Research, Taylor & Francis, London, UK, 2002.
61. J. R. Jones, C. Barrick, K.-A. Kim, et al., "Deletion of PPAR in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 17, pp. 6207-6212, 2005.
62. E. John, A. Wienecke-Baldacchino, M. Liivrand, M. Heinäniemi, C. Carlberg, and L. Sinkkonen, "Dataset integration identifies transcriptional regulation of microRNA genes by PPAR in differentiating mouse 3T3-L1 adipocytes, " Nucleic Acids Research, vol. 40, no. 10, pp. 4446-4460, 2012.
63. L. Fajas, R. L. Landsberg, Y. Huss-Garcia, C. Sardet, J. A. Lees, and J. Auwerx, "E2Fs regulate adipocyte differentiation, " Developmental Cell, vol. 3, no. 1, pp. 39-49, 2002.
64. S. A. Kliewer, J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, and J. M. Lehmann, "A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor and promotes adipocyte differentiation, " Cell, vol. 83, no. 5, pp. 813-819, 1995.
65. A. Jozkowicz, J. Dulak, E. Piatkowska, W. Placha, and A. Dembinska-Kiec, "Ligands of peroxisome proliferatoractivated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages, " Acta Biochimica Polonica, vol. 47, no. 4, pp. 1147-1157, 2000.
66. H. Migita and J. Morser, "15-Deoxy-12, 14-postaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-but not peroxisome proliferator-activated receptor-in human vascular endothelial cells: the effect of 15d-PGJ2 ontumor necrosis factor-induced gene expression, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 4, pp. 710-716, 2005.
67. H. Sundvold and S. Lien, "Identification of a novel peroxisome proliferator-activated receptor (PPAR) gamma promoter in man and transactivation by the nuclear receptor RORalpha1, " Biochemical and Biophysical Research Communications, vol. 287, no. 2, pp. 383-390, 2001.
68. P. Lau, P. Bailey, D. H. Dowhan, and G. E. O. Muscat, "Exogenous expression of a dominant negative ROR1 vector inmuscle cells impairs differentiation: ROR1 directly interacts with p300 and MyoD, " Nucleic Acids Research, vol. 27, no. 2, pp. 411-420, 1999.
69. S. J. Matkovich, Y. Hu, and G. W. Dorn II, "Regulation of cardiac microRNAs by cardiac microRNAs, " Circulation Research, vol. 113, no. 1, pp. 62-71, 2013.
70. A. Musaro, "The basis of muscle regeneration, " Advances in Biology, vol. 2014, Article ID 612471, 16 pages, 2014.
71. M. H. Parker, P. Seale, and M. A. Rudnicki, "Looking back to the embryo: defining transcriptional networks in adult myogenesis, " Nature Reviews Genetics, vol. 4, no. 7, pp. 497-507, 2003.
72. P. K. Davidsen, I. J. Gallagher, J. W. Hartman, et al., "High responders to resistance exercise training demonstrate differential regulation of skeletalmuscle microRNAexpression, " Journal of Applied Physiology, vol. 110, no. 2, pp. 309-317, 2011.
73. J. Fang, X.-W. Song, J. Tian, et al., "Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiacmyocytes, " Apoptosis, vol. 17, no. 4, pp. 410-423, 2012.
74. S. W. Kim, H. W. Kim, W. Huang, et al., "Cardiac stem cells with electrical stimulation improve ischaemic heart function through regulation of connective tissue growth factor and miR-378, " Cardiovascular Research, vol. 100, no. 2, pp. 241-251, 2013.
75. F. Megiorni, S. Cialfi, H. P. McDowell, et al., "Deep sequencing the microRNA profile in rhabdomyosarcoma reveals downregulation of miR-378 family members, " BMC Cancer, vol. 14, article 880, 2014.
76. M. Tranter, R. N. Helsley, W. R. Paulding, et al., "Coordinated post-transcriptional regulation of Hsp70. 3 gene expression by microRNA and alternative polyadenylation, " The Journal of Biological Chemistry, vol. 286, no. 34, pp. 29828-29837, 2011.
77. R. S. Nagalingam, N. R. Sundaresan, M. P. Gupta, D. L. Geenen, R. J. Solaro, and M. Gupta, "A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling, " The Journal of Biological Chemistry, vol. 288, no. 16, pp. 11216-11232, 2013.
78. J. Ganesan, D. Ramanujam, Y. Sassi, et al., "MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors, " Circulation, vol. 127, no. 21, pp. 2097-2106, 2013.
79. L. Jeanson-Leh, J. Lameth, S. Krimi, et al., "Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in golden retriever muscular dystrophy dogs and duchenne muscular dystrophy patients, " American Journal of Pathology, vol. 184, no. 11, pp. 2885-2898, 2014.
80. P. Carmeliet and R. K. Jain, "Molecular mechanisms and clinical applications of angiogenesis, " Nature, vol. 473, no. 7347, pp. 298-307, 2011.
81. S. Wang and E. N. Olson, "AngiomiRs-Key regulators of angiogenesis, " Current Opinion in Genetics and Development, vol. 19, no. 3, pp. 205-211, 2009.
82. D. J. Manalo, A. Rowan, T. Lavoie, et al., "Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1, " Blood, vol. 105, no. 2, pp. 659-669, 2005.
83. J. A. Forsythe, B.-H. Jiang, N. V. Iyer, et al., "Activation of vascular endothelial growth factor gene transcription by hypoxiainducible factor 1, "Molecular and Cellular Biology, vol. 16, no. 9, pp. 4604-4613, 1996.
84. A. Loboda, A. Jozkowicz, and J. Dulak, "HIF-1 and HIF-2 transcription factors-similar but not identical, " Molecules and Cells, vol. 29, no. 5, pp. 435-442, 2010.
85. A. Loboda, A. Jozkowicz, and J. Dulak, "HIF-1 versus HIF-2-is one more important than the other?" Vascular Pharmacology, vol. 56, no. 5-6, pp. 245-251, 2012.
86. U. Florczyk, A. Jazwa, M. Maleszewska, et al., "Nrf2 regulates angiogenesis: effect on endothelial cells, bone marrow-derived proangiogenic cells and hind limb ischemia, " Antioxidants and Redox Signaling, vol. 20, no. 11, pp. 1693-1708, 2014.
87. A. Loboda, A. Stachurska, U. Florczyk, et al., "HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells, " Antioxidants and Redox Signaling, vol. 11, no. 7, pp. 1501-1517, 2009.
88. M. Feng, Z. Li, M. Aau, C. H. Wong, X. Yang, and Q. Yu, "Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation, " Oncogene, vol. 30, no. 19, pp. 2242-2251, 2011.
89. Z. Hua, Q. Lv, W. Ye, et al., "Mirna-directed regulation of VEGF and other angiogenic under hypoxia, " PLoS ONE, vol. 1, no. 1, article e116, 2006.
90. T. Nagase, M. Nagase, K. Yoshimura, T. Fujita, and I. Koshima, "Angiogenesis within the developing mouse neural tube is dependent on sonic hedgehog signaling: possible roles ofmotor neurons, " Genes to Cells, vol. 10, no. 6, pp. 595-604, 2005.
91. R. Pola, L. E. Ling, M. Silver, et al., "The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors, " Nature Medicine, vol. 7, no. 6, pp. 706-711, 2001.
92. K. J. Lavine, A. C. White, C. Park, et al., "Fibroblast growthfactor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development, " Genes and Development, vol. 20, no. 12, pp. 1651-1666, 2006.
93. Y. Xing, J. Hou, T. Guo, et al., "microRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic-ischemic conditions in vitro, " Stem Cell Research & Therapy, vol. 5, no. 6, article 130, 2014.
94. Z. Arany, S.-Y. Foo, Y. Ma, et al., "HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1, " Nature, vol. 451, no. 7181, pp. 1008-1012, 2008.
95. J. Jiang, E. J. Lee, Y. Gusev, and T. D. Schmittgen, "Real-time expression profiling of microRNA precursors in human cancer cell lines, " Nucleic Acids Research, vol. 33, no. 17, pp. 5394-5403, 2005.
96. J. Guo, Y. Miao, B. Xiao, et al., "Differential expression of microRNA species in human gastric cancer versus nontumorous tissues, " Journal of Gastroenterology and Hepatology, vol. 24, no. 4, pp. 652-657, 2009.
97. Y. Yao, A. L. Suo, Z. F. Li, et al., "MicroRNA profiling of human gastric cancer, " Molecular Medicine Reports, vol. 2, no. 6, pp. 963-970, 2009.
98. L. Scapoli, A. Palmieri, L. Lo Muzio, et al., "MicroRNA expression profiling of oral carcinoma identifies newmarkers of tumor progression, " International Journal of Immunopathology and Pharmacology, vol. 23, no. 4, pp. 1229-1234, 2010.
99. Y. X. Wang, X. Y. Zhang, B. F. Zhang, C. Q. Yang, X. M. Chen, and H. J. Gao, "Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis, " Journal of Digestive Diseases, vol. 11, no. 1, pp. 50-54, 2010.
100. M. Redova, A. Poprach, J. Nekvindova, et al., "Circulating miR-and miR-451 in serum are potential biomarkers for renal cell carcinoma, " Journal of Translational Medicine, vol. 10, no. 1, article 55, 2012.
101. K. Skrzypek, M. Tertil, S. Golda, et al., "Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis, " Antioxidants and Redox Signaling, vol. 19, no. 7, pp. 644-660, 2013.
102. H. C. N. Nguyen, W. Xie, M. Yang, et al., "Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer, " Prostate, vol. 73, no. 4, pp. 346-354, 2013.
103. M. Fedorko, M. Stanik, R. Iliev, et al., "Combination ofMiR-378 and MiR-210 serum levels enables sensitive detection of renal cell carcinoma, " International Journal ofMolecular Sciences, vol. 16, no. 10, pp. 23382-23389, 2015.
104. H. Liu, L. Zhu, B. Liu, et al., "Genome-widemicroRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer, " Cancer Letters, vol. 316, no. 2, pp. 196-203, 2012.
105. J. Qian, J. Lin, W. Qian, et al., "Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia, " Leukemia Research, vol. 37, no. 7, pp. 765-768, 2013.
106. J. Ma, J. Lin, J. Qian, et al., "MiR-378 promotes the migration of liver cancer cells by down-regulating fus expression, " Cellular Physiology and Biochemistry, vol. 34, no. 6, pp. 2266-2274, 2014.
107. K. Skrzypek, A. Kusienicka, B. Szewczyk, et al., "Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression, " Oncotarget, vol. 6, no. 31, pp. 31378-31398, 2015.
108. A. Jazwa, A. Loboda, S. Golda, et al., "Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes, " Free Radical Biology and Medicine, vol. 40, no. 7, pp. 1250-1263, 2006.
109. H. Was, J. Dulak, and A. Jozkowicz, "Heme oxygenase-1 in tumor biology and therapy, " Current Drug Targets, vol. 11, no. 12, pp. 1551-1570, 2010.
110. M. Terti, K. Skrzypek, U. Florczyk, et al., "Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1, " PLoS ONE, vol. 9, no. 5, Article ID e97070, 2014.
111. M. Tertil, S. Golda, K. Skrzypek, et al., "Nrf2-heme oxygenase-axis in mucoepidermoid carcinoma of the lung: antitumoral effects associated with down-regulation of matrix metalloproteinases, " FreeRadical Biology andMedicine, vol. 89, pp. 147-157, 2015.
112. F. Liu, Q. Lv, W. W. Du, et al., "Specificity of miR-378a-5p targeting rodent fibronectin, " Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1833, no. 12, pp. 3272-3285, 2013.
113. J. K. Chan, T. K. Kiet, K. Blansit, et al., "MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer, " Gynecologic Oncology, vol. 133, no. 3, pp. 568-574, 2014.
114. H.-C. Li, J.-P. Li, Z.-M. Wang, et al., "Identification of angiogenesis-related miRNAs in a population of patients with renal clear cell carcinoma, " Oncology Reports, vol. 32, no. 5, pp. 2061-2069, 2014.
115. W.-H. Weng, W.-H. Leung, Y.-J. Pang, and H.-H. Hsu, "Lauric acid can improve the sensitization of Cetuximab in KRAS/BRAF mutated colorectal cancer cells by retrievable microRNA-378 expression, " Oncology Reports, 2015.
116. H. Li, L. Chang, W. W. Du, et al., "Anti-microRNA-378a enhances wound healing process by upregulating integrin beta-and vimentin, " Molecular Therapy, vol. 22, no. 10, pp. 1839-1850, 2014.
117. G. C. Rowe, C. Jang, I. S. Patten, and Z. Arany, "PGC-1 regulates angiogenesis in skeletal muscle, " American Journal of Physiology: Endocrinology and Metabolism, vol. 301, no. 1, pp. E155-E163, 2011.
118. V. Yadav, A. Matsakas, S. Lorca, and V. A. Narkar, "PGC1 activates an antiangiogenic programto repress neoangiogenesis inmuscle ischemia, " Cell Reports, vol. 8, no. 3, pp. 783-797, 2014.
119. C. Stockmann, D. Schadendorf, R. Klose, and I. Helfrich, "The impact of the immune system on tumor: angiogenesis and vascular remodeling, " Frontiers in Oncology, vol. 4, article 69, 2014.
120. M. Ono, "Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy, " Cancer Science, vol. 99, no. 8, pp. 1501-1506, 2008.
121. B. J. Nickoloff, "Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis, " Journal of Investigative Dermatology Symposium Proceedings, vol. 5, no. 1, pp. 67-73, 2000.
122. A. Naldini, A. Pucci, C. Bernini, and F. Carraro, "Regulation of angiogenesis by Th1-and Th2-type cytokines, " Current Pharmaceutical Design, vol. 9, no. 7, pp. 511-519, 2003.
123. S. E. J. Chambers, C. L. ONeill, T. M. ODoherty, R. J. Medina, and A. W. Stitt, "The role of immune-related myeloid cells in angiogenesis, " Immunobiology, vol. 218, no. 11, pp. 1370-1375, 2013.
124. P. Wang, Y. Gu, Q. Zhang, et al., "Identification of resting and type I IFN-activated human NK cell miRNomes reveals MicroRNA-378 and MicroRNA-30e as negative regulators of NK cell cytotoxicity, " The Journal of Immunology, vol. 189, no. 1, pp. 211-221, 2012.
125. S. Liu, L. Chen, Y. Zeng, et al., "Suppressed expression of miR-targeting gzmb in NK cells is required to control dengue virus infection, " Cellular & Molecular Immunology, 2015.
126. F. O. Martinez, A. Sica, A. Mantovani, and M. Locati, "Macrophage activation and polarization, " Frontiers in Bioscience, vol. 13, pp. 453-461, 2008.
127. G. Liu and E. Abraham, "MicroRNAs in immune response andmacrophage polarization, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 2, pp. 170-177, 2013.
128. D. Zhou, C. Huang, Z. Lin, et al., "Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways, " Cellular Signalling, vol. 26, no. 2, pp. 192-197, 2014.
129. D. Rückerl, S. J. Jenkins, N. N. Laqtom, et al., "Induction of IL-4Ralpha-dependent microRNAs identifies PI3K/Akt signaling as essential for IL-4-drivenmurinemacrophage proliferation in vivo, " Blood, vol. 120, no. 11, pp. 2307-2316, 2012.
130. X. Jiang, M. Xue, Z. Fu, et al., "Insight into the effects of adipose tissue inflammation factors on miR-378 expression and the underlying mechanism, " Cellular Physiology and Biochemistry, vol. 33, no. 6, pp. 1778-1788, 2014.
131. T. Kagiya and S. Nakamura, "Expression profiling of microRNAs in RAW264. 7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation, " Journal of Periodontal Research, vol. 48, no. 3, pp. 373-385, 2013.
132. B. Ell, L. Mercatali, T. Ibrahim, et al., "Tumor-induced osteoclast miRNAchanges as regulators and biomarkers of osteolytic bone metastasis, " Cancer Cell, vol. 24, no. 4, pp. 542-556, 2013.